Charles J. Homcy, Director at Global Blood Therapeutics, Inc. (GBT), sold 70,000 shares at $33.93 ($2.4M) on 2017-10-26, disclosed to the SEC on 2017-10-27.
Open-market sale of $2.4M GBT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.93 | 54,400 | $1.8M | 77.6% |
| 2 | $34.09 | 15,600 | $532K | 22.4% |
| Total | $33.97 avg | 70,000 | $2.4M | 100% |
| Filing → |
| BBIO | SELL | 2020-10-01 | $380K | — | Filing → |
| BBIO | SELL | 2020-09-29 | $6.7M | — | Filing → |
| BBIO | SELL | 2020-02-12 | $720K | — | Filing → |